- Home
- FDMT vs TSAT Comparison
FDMT vs TSAT Comparison
Compare FDMT & TSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FDMT | TSAT |
|---|---|---|
| Founded | 2013 | 1969 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 695.3M | 697.5M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FDMT | TSAT |
|---|---|---|
| Price | $10.38 | $37.75 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 1 |
| Target Price | $31.71 | ★ $37.00 |
| AVG Volume (30 Days) | ★ 794.2K | 198.3K |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $85,209,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $70.28 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 230194.60 | N/A |
| 52 Week Low | $4.27 | $19.59 |
| 52 Week High | $14.00 | $59.12 |
Technical Indicators
Market Signals| Indicator | FDMT | TSAT |
|---|---|---|
| Relative Strength Index (RSI) | 42.01 | 39.38 |
| Support Level | $9.71 | $36.06 |
| Resistance Level | $10.50 | $43.82 |
| Average True Range (ATR) | 0.79 | 2.66 |
| MACD | -0.30 | -0.03 |
| Stochastic Oscillator | 10.76 | 11.89 |
Price Performance
Historical ComparisonAbout FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
About TSAT Telesat Corporation
Telesat Corp is a satellite operator, that provides its customers with mission-critical communications services. It operates in a single operating segment, in which it provides satellite-based services to its broadcast, enterprise, and consulting customers around the world. The company has two operating segments: GEO services (GEO) segment that refers to the operation of the fleet of GEO satellite and LEO services (LEO) segment that refers to the deployment and operation of the Telesat Lightspeed constellation Geographically, it derives a majority of its revenue from Canada. It derives revenue from Broadcast, Enterprise, Consulting, and others.